Robert Whitbourn

8.0k total citations
157 papers, 5.0k citations indexed

About

Robert Whitbourn is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert Whitbourn has authored 157 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Cardiology and Cardiovascular Medicine, 97 papers in Surgery and 53 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert Whitbourn's work include Coronary Interventions and Diagnostics (87 papers), Cardiac Imaging and Diagnostics (45 papers) and Cardiac Valve Diseases and Treatments (43 papers). Robert Whitbourn is often cited by papers focused on Coronary Interventions and Diagnostics (87 papers), Cardiac Imaging and Diagnostics (45 papers) and Cardiac Valve Diseases and Treatments (43 papers). Robert Whitbourn collaborates with scholars based in Australia, United States and New Zealand. Robert Whitbourn's co-authors include Ian T. Meredith, Patrick W. Serruys, Yoshinobu Onuma, John A. Ormiston, Bernard Chevalier, Dougal McClean, Peter J. Fitzgerald, Susan Veldhof, Jacques Koolen and Héctor M. García‐García and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Hypertension.

In The Last Decade

Robert Whitbourn

149 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Whitbourn Australia	38	3.5k	3.2k	1.6k	1.4k	444	157	5.0k
Kenichi Sakakura Japan	30	2.7k 0.8×	2.7k 0.8×	1.3k 0.8×	1.3k 0.9×	221 0.5×	255	4.6k
Peter P.T. de Jaegere Netherlands	42	3.7k 1.1×	5.4k 1.7×	1.5k 0.9×	1.6k 1.1×	1.8k 4.1×	138	6.8k
Evald Høj Christiansen Denmark	45	5.6k 1.6×	5.4k 1.7×	1.4k 0.9×	3.9k 2.7×	474 1.1×	293	8.9k
Luigi Chiariello Italy	37	1.9k 0.5×	2.8k 0.9×	1.5k 1.0×	617 0.4×	844 1.9×	200	4.6k
Franco Fabbiocchi Italy	29	1.5k 0.4×	1.5k 0.5×	1.2k 0.7×	1.0k 0.7×	326 0.7×	108	3.6k
Anne Kaltoft Denmark	33	2.9k 0.8×	3.0k 0.9×	450 0.3×	2.4k 1.7×	100 0.2×	99	4.8k
Jan Baan Netherlands	39	2.8k 0.8×	3.4k 1.1×	986 0.6×	1.3k 0.9×	819 1.8×	194	5.4k
Neal D. Kon United States	29	1.3k 0.4×	2.6k 0.8×	924 0.6×	246 0.2×	643 1.4×	105	3.3k
Leonard M. Shapiro United Kingdom	39	1.8k 0.5×	3.0k 0.9×	1.0k 0.6×	1.3k 0.9×	515 1.2×	136	5.0k
Joo Myung Lee South Korea	36	2.8k 0.8×	2.5k 0.8×	710 0.4×	2.4k 1.7×	200 0.5×	249	4.3k

Countries citing papers authored by Robert Whitbourn

Since Specialization

Citations

This map shows the geographic impact of Robert Whitbourn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Whitbourn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Whitbourn more than expected).

Fields of papers citing papers by Robert Whitbourn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Whitbourn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Whitbourn. The network helps show where Robert Whitbourn may publish in the future.

Co-authorship network of co-authors of Robert Whitbourn

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Whitbourn. A scholar is included among the top collaborators of Robert Whitbourn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Whitbourn. Robert Whitbourn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sinhal, A., Jayme Bennetts, Ravinay Bhindi, et al.. (2025). Australian Cardiac Outcomes Registry of Transcatheter Aortic Valve Implantation: Report and Update of Transcatheter Aortic Valve Implantation in Australia. Heart Lung and Circulation. 34(5). 472–484. 1 indexed citations

Mahfoud, Felix, Raymond R. Townsend, Giuseppe Mancia, et al.. (2024). POOLED, LONG-TERM ANALYSIS OF THE GLOBAL SYMPLICITY CLINICAL TRIAL PROGRAM OF RADIOFREQUENCY RENAL DENERVATION FOR THE TREATMENT OF UNCONTROLLED HYPERTENSION. Journal of Hypertension. 42(Suppl 1). e17–e17. 2 indexed citations

Ha, F., et al.. (2024). The Use of the Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Predicting Transcatheter Aortic Valve Implantation Mortality. Heart Lung and Circulation. 33(12). 1680–1687. 3 indexed citations

Arunothayaraj, Sandeep, James Cockburn, James D. Newton, et al.. (2021). Procedural Mortality With Transcatheter Aortic Valve Replacement – Balloon Inflation is Associated With Increased Risk. The Journal of invasive cardiology. 33(10). E761–E768. 1 indexed citations

Meredith, Ian T., Vicki M Houle, D. Walters, et al.. (2016). TCT-39 Three-Year Outcomes with the Fully Repositionable and Retrievable Lotus™ Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study. Journal of the American College of Cardiology. 68(18). B16–B17.

Campos, Carlos M., Alexandre Abizaid, Adriano Caixeta, et al.. (2016). TCT-411 Risk and timing of clinical events according to diabetic status of patients treated with Everolimus-Eluting Bioresorbable Vascular Scaffolds vs. Everolimus-Eluting stent: 2-Year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials. Journal of the American College of Cardiology. 68(18). B167–B167. 1 indexed citations

Meredith, Ian T., D. Walters, Nicolas Dumonteil, et al.. (2014). RESULTS OF THE REPOSITIONABLE PERCUTANEOUS REPLACEMENT OF STENOTIC AORTIC VALVE WITH THE LOTUS™ VALVE SYSTEM – EVALUATION OF SAFETY AND PERFORMANCE (REPRISE II) STUDY: 3-MONTH OUTCOMES IN HIGH-RISK SURGICAL PATIENTS. Journal of the American College of Cardiology. 63(12). A1957–A1957.

Onuma, Yoshinobu, Patrick W. Serruys, Takashi Muramatsu, et al.. (2014). Incidence and Imaging Outcomes of Acute Scaffold Disruption and Late Structural Discontinuity After Implantation of the Absorb Everolimus-Eluting Fully Bioresorbable Vascular Scaffold. JACC: Cardiovascular Interventions. 7(12). 1400–1411. 87 indexed citations

Onuma, Yoshinobu, Héctor M. García‐García, Jacques Koolen, et al.. (2013). TCT-34 The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices - Insights from the ABSORB Cohort B trial using three-dimensional optical coherence tomography. Journal of the American College of Cardiology. 62(18). B12–B12. 3 indexed citations

10.

Muramatsu, Takashi, Yoshinobu Onuma, Héctor M. García‐García, et al.. (2013). Incidence and Short-Term Clinical Outcomes of Small Side Branch Occlusion After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold. JACC: Cardiovascular Interventions. 6(3). 247–257. 77 indexed citations

11.

Ormiston, John A., Mark Webster, James T. Stewart, et al.. (2013). First-in-Human Evaluation of a Bioabsorbable Polymer–Coated Sirolimus-Eluting Stent. JACC: Cardiovascular Interventions. 6(10). 1026–1034. 24 indexed citations

12.

Meredith, Ian T., Robert Whitbourn, Douglas Scott, et al.. (2011). PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses. EuroIntervention. 7(1). 84–90. 30 indexed citations

13.

Gómez‐Lara, Josep, Salvatore Brugaletta, Vasim Farooq, et al.. (2011). Head-to-Head Comparison of the Neointimal Response Between Metallic and Bioresorbable Everolimus-Eluting Scaffolds Using Optical Coherence Tomography. JACC: Cardiovascular Interventions. 4(12). 1271–1280. 51 indexed citations

14.

Meredith, Ian T., Stephen G. Worthley, Robert Whitbourn, et al.. (2010). Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial. EuroIntervention. 5(6). 692–697. 30 indexed citations

15.

Okamura, Takayuki, Yoshinobu Onuma, Héctor M. García‐García, et al.. (2010). 3-Dimensional Optical Coherence Tomography Assessment of Jailed Side Branches by Bioresorbable Vascular Scaffolds. JACC: Cardiovascular Interventions. 3(8). 836–844. 74 indexed citations

16.

Schlaich, Markus P., Paul A. Sobotka, Henry Krum, et al.. (2009). Renal Denervation as a Therapeutic Approach for Hypertension. Hypertension. 54(6). 1195–1201. 178 indexed citations

17.

Meredith, Ian T., John A. Ormiston, Robert Whitbourn, et al.. (2009). Five‐year clinical follow‐up after implantation of the endeavor zotarolimus‐eluting stent: ENDEAVOR I, first‐in‐human study. Catheterization and Cardiovascular Interventions. 74(7). 989–995. 17 indexed citations

18.

Meredith, Ian T., Stephen G. Worthley, Robert Whitbourn, et al.. (2009). Clinical and Angiographic Results With the Next-Generation Resolute Stent System. JACC: Cardiovascular Interventions. 2(10). 977–985. 96 indexed citations

19.

Wilson, Andrew M., Hui Ding, Y. Zhang, et al.. (2006). Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy. Atherosclerosis. 191(1). 175–181. 33 indexed citations

20.

Whitbourn, Robert & Stephen N. Oesterle. (1998). State of the Art: Trans‐ and Percutaneous Myocardial Revascularization. Journal of Interventional Cardiology. 11(6). 609–613.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact